Leech Biotechnology, Defining New Standards of Potency.
English
| Place of Origin: | China |
|---|---|
| Brand Name: | yichilam |
| Certification: | ISO9001；ISO45001；ISO12001；certificate of origin；Quarantine certificate |
| Model Number: | yzl-d-086 |
| Minimum Order Quantity: | 1000 |
| Packaging Details: | Standard Packages |
| Delivery Time: | 10-20 Days |
| Payment Terms: | T/T, L/C, D/P, Western Union |
| Supply Ability: | Medical leech factory: annual output > 100 million medical leeches |
| Name: | Medical Leech | Source: | Hirudo Nipponia |
|---|---|---|---|
| Specifications: | 3 Pieces/Bottle | Store: | 4℃ |
| Shelf Life: | 45 Days | Similar Products: | Hirudo Verbana |
| Highlight: | Native Hirudo Leech,Therapeutic Hirudo Leech,Therapeutic hirudo medicinalis |
||
Air transport 3 Pieces/Bottle Hungry living Hirudo nipponia for Leech therapy form China
Discover Hirudo nipponia: A Modern Medical Solution
1. The Legacy of Hirudo nipponia
Hirudo nipponia, a medicinal leech species native to China, boasts a rich therapeutic heritage spanning over two millennia. This time-honored biological resource continues to serve as a cornerstone in medical applications, bridging ancient wisdom with contemporary needs.
2. The Science Behind Medicinal Leeches
Medicinal leeches represent a specialized category within hirudotherapy, comprising species like Hirudo nipponia, Hirudo verbana, and Hirudo medicinalis. Their medicinal application constitutes one of humanity's oldest continuous medical traditions, documented across civilizations from ancient India's Sushruta Samhita to classical Greek medical practices. This enduring therapeutic modality maintains significant relevance in modern medical practice, particularly within Eastern medical traditions.
3. The Mechanism of Hirudotherapy
Hirudotherapy employs medicinal leeches as natural biochemical delivery systems. Through precise dermal attachment, these organisms administer a sophisticated cocktail of bioactive compounds—including potent anticoagulants, analgesics, and anti-inflammatory agents—directly to affected tissues. This natural mechanism promotes microcirculation, prevents thrombus formation, and supports tissue viability, making it particularly valuable in reconstructive microsurgery and managing vascular complications.
4. Competitive Advantages of Hirudo nipponia
• Sustainable Sourcing: While related species face CITES trade restrictions, Hirudo nipponia offers an unrestricted, commercially viable alternative, ensuring stable global supply chains without regulatory limitations.
• Optimized Bio-Mechanics: Featuring an intermediate dentition profile (60-100 teeth per jaw), Hirudo nipponia achieves optimal balance between incision efficacy and tissue preservation, reducing procedural trauma while maintaining therapeutic effectiveness.
Technical Specifications
Standard product configurations are readily available, complemented by flexible customization options to address specific clinical or research requirements.
Value Proposition & Quality Assurance
Integrated Supply Chain Excellence: Our vertically integrated operations—encompassing genetic research, advanced aquaculture, and GMP-compliant processing—ensure unparalleled quality control from propagation to final product. With a 24,000 m² production facility and annual output capacity of 100-500 million leeches, we guarantee consistent supply, complete traceability, and exceptional cost efficiency.
Global Compliance Capability: Our internationally-experienced team facilitates seamless cross-border transactions, supported by comprehensive certification packages (ISO 9001/45001/14001, Origin and Quarantine Certificates).
Industry Leadership: As China's premier medical leech producer, we provide partners with exclusive market intelligence and technical insights, fostering informed decision-making in this specialized sector.
Corporate Overview
Jingzhou Minkang Biotechnology Co., Ltd. stands as the definitive leader in medical leech biotech, leveraging 26 years of specialized expertise. Through proprietary industrial-scale cultivation systems operating within 14,000 m² of advanced purification facilities, we maintain annual production benchmarks of 60 million juveniles and 100 million adults—scalable to 500 million at full capacity. Our technological supremacy and production scale cement our position as China's undisputed industry pioneer.